ロード中...
Fixed Dosing of Monoclonal Antibodies in Oncology
Most monoclonal antibodies in oncology are administered in body–size‐based dosing schedules. This is believed to correct for variability in both drug distribution and elimination between patients. However, monoclonal antibodies typically distribute to the blood plasma and extracellular fluids only,...
保存先:
| 出版年: | Oncologist |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
AlphaMed Press
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5634778/ https://ncbi.nlm.nih.gov/pubmed/28754722 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0167 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|